MedAvail Appoints Ramona Seabaugh as Chief Financial Officer
September 20 2021 - 8:00AM
Business Wire
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the
“Company”), a technology-enabled pharmacy company, today announced
the appointment of Ramona Seabaugh as Chief Financial Officer
effective immediately. As a key member of MedAvail’s executive
leadership team, Ms. Seabaugh will lead the Company’s financial
operations.
“Ramona’s pharmacy industry expertise and extensive financial
leadership experience will be invaluable in executing our strategy
to drive operational and financial performance,” said Ed Kilroy,
President and Chief Executive Officer of MedAvail. “I am pleased to
welcome Ramona to our team, as we continue to expand into new
geographies and transform the pharmacy experience for seniors.”
Ms. Seabaugh brings to MedAvail more than 20 years of experience
with pharmacy and healthcare services organizations leading
strategic growth initiatives. She most recently served as Vice
President of Finance at Vixxo Corporation, a facilities management
company. Prior to Vixxo, Ms. Seabaugh served as the Vice President
of Finance at Ascension Pharmacy Services, a division within one of
the largest non-profit health systems in the United States.
Previously, she was appointed as Chief Financial Officer of Banner
Pharmacy Services, a division within Banner Health. Earlier in her
career, Ms. Seabaugh held various leadership positions in finance,
including with Millennium Pharmacy Systems, Walgreens Company,
Astellas Pharma and Caremark Rx. She holds a Bachelor of Science in
Finance from the University of Wisconsin and an MBA from Lake
Forest Graduate School.
“MedAvail has a unique embedded pharmacy model and a tremendous
market opportunity with Medicare beneficiaries,” said Ms. Seabaugh.
“I look forward to helping the team accelerate MedAvail’s growth
and create additional value for MedAvail shareholders.”
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled
pharmacy organization, providing turnkey in-clinic pharmacy
services through its proprietary robotic dispensing platform, the
MedAvail MedCenter, and home delivery operations, to Medicare
clinics. MedAvail helps patients to optimize drug adherence,
resulting in better health outcomes. Learn more at
www.medavail.com.
Forward Looking Statements
Certain statements included in this press release that are not
historical facts are forward-looking statements for purposes of the
safe harbor provisions under the Private Securities Litigation
Reform Act of 1995. Forward-looking statements generally are
accompanied by words such as "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect," "should," "would,"
"plan," "predict," "potential," "seem," "seek," "future,"
"outlook," "project," and similar expressions that predict or
indicate future events or trends or that are not statements of
historical matters. These forward-looking statements include, but
are not limited to, statements regarding MedAvail's business
strategy and market opportunity; potential future revenue
projections and expectations for growth; expansion plans; and
customer partnerships; and perception of the regulatory landscape.
These statements are based on various assumptions, whether or not
identified in this press release, and on the current expectations
of MedAvail's management and are not predictions of actual
performance. Forward-looking statements are subject to a number of
risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements, including but not
limited to general economic, financial, legal, political and
business conditions and changes in domestic and foreign markets;
the potential effects of COVID-19; the uncertainty in the timing or
receipt of regulatory approvals; changes in competitive conditions
prevailing in the healthcare sector; the availability of capital;
and the other risks discussed under the heading "Risk Factors" in
our Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (“SEC”) on March 31, 2021 and our Quarterly
Report on Form 10-Q, filed with the SEC on August 12, 2021, and
other documents MedAvail files with the SEC in the future. If any
of these risks materialize or our assumptions prove incorrect,
actual results could differ materially from the results implied by
these forward-looking statements. These forward-looking statements
speak only as of the date hereof and MedAvail specifically
disclaims any obligation to update these forward-looking
statements.
SOURCE MedAvail Holdings Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210920005276/en/
Investor Relations Caroline Paul Gilmartin Group
ir@medavail.com
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024